Horizon Therapeutics Plc (HZNP) has a PEG ratio of 47.06, above the Healthcare sector average of 2.56.
Get informed when a big investor buys or sells
+ Follow47.06
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, HZNP shows a PEG ratio of 47.06. That is above the Healthcare sector average of 2.56. Scroll down for historical charts and peer comparison views.
The Healthcare sector average PEG ratio is about 2.56. Horizon Therapeutics Plc is at 47.06, which is higher that average. That is roughly 1738.3% above the sector mean. Use the comparison chart on this page to see how HZNP stacks up against individual peers as well.
Investors watch HZNP's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Horizon Therapeutics Plc's latest reading is 47.06. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has Horizon Therapeutics Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 47.06) with ownership activity and broader fundamentals.
The Healthcare average PEG ratio is about 2.56, while HZNP is at 47.06. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.